PAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference
PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that
Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare
Conference on Wednesday, September 27, 2017 at 10:55 a.m. Eastern time. Dr. Aklog will provide a corporate overview, discuss the
Company’s innovative business model and review PAVmed’s lead products. The conference is taking place at the InterContinental New
York Barclay Hotel in New York City on September 25-27, 2017.
To access the live webcast of the presentation, please click here. A replay will be available following the presentation.
About PAVmed Inc.
PAVmed Inc. (Nasdaq: PAVM, PAVMW) is a highly differentiated, multi-product medical device company employing a unique business
model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the
typical medical device company. This proprietary model enables PAVmed to pursue an expanding multi-product pipeline strategy with a
view to enhancing and accelerating value creation. PAVmed’s diversified pipeline of products address unmet clinical needs, have
attractive regulatory pathways and market opportunities and encompass a broad spectrum of clinical areas including carpal tunnel
syndrome (CarpX™), medical infusions (NextFlo™ and NextCath™), interventional radiology (PortIO™ and NextCath), tissue ablation and
cardiovascular intervention (Caldus™) and pediatric ear infections (DisappEAR™).
Investors
LHA Investor Relations
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
or
info@pavmed.com
or
Media
Rooney Partners
Kate Barrette, 212-223-0561
kbarrette@rooneyco.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170918005170/en/